True Wealth Design LLC bought a new position in Exelixis, Inc. (NASDAQ:EXEL – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 34,516 shares of the biotechnology company’s stock, valued at approximately $828,000. Other hedge funds and other […]
True Wealth Design LLC bought a new stake in Exelixis, Inc. (NASDAQ:EXEL – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 34,516 shares of the biotechnology company’s stock, valued at approximately $828,000. Other hedge funds have also […]
Exelixis (NASDAQ:EXEL – Get Free Report) was downgraded by analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a note issued to investors on Tuesday. Other equities analysts have also issued reports about the company. Royal Bank of Canada upped their target price on Exelixis from $26.00 to $28.00 and gave the […]
Exelixis (NASDAQ:EXEL – Get Free Report) was downgraded by analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a note issued to investors on Tuesday. Other equities analysts have also issued reports about the company. Royal Bank of Canada upped their target price on Exelixis from $26.00 to $28.00 and gave the […]
Shares of Exelixis, Inc. (NASDAQ:EXEL – Get Free Report) have received a consensus rating of “Moderate Buy” from the seventeen brokerages that are currently covering the firm, Marketbeat Ratings reports. Seven equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. The average 1-year […]